A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus
Status:
Recruiting
Trial end date:
2022-08-17
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the efficacy and safety of LY3502970 in
participants with type 2 diabetes (T2D) who failed to achieve adequate glycemic control on
diet and exercise alone or on a stable dose of metformin. This study will last about 30
weeks.